Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
---|
11/04/2010 | CA2758965A1 Methods for the preparation of amphiphilic nitrogen containing imidazolinium derivative compounds |
11/03/2010 | EP2245022A2 Antagonists of prostaglandin d2 receptors |
11/03/2010 | EP1831179B1 Method for the production of onium salts with tetrafluoroborate anion having a reduced halide content |
11/03/2010 | EP1496838B1 Substituted amides |
11/03/2010 | CN101878202A Gamma secretase modulators |
11/03/2010 | CN101875636A Imidazoline-2,4-diketone derivative and preparation method and applications thereof |
11/03/2010 | CN101875635A Annular guanidinium ionic liquid and preparation method therof |
11/03/2010 | CN101215330B Method for preparing 1-aminohydantoin artificial antigen |
11/02/2010 | US7825259 Method of preparation of halogen-free ionic liquids and ionic liquids prepared in this manner |
11/02/2010 | US7825193 Dithiocarbamic esters |
11/02/2010 | US7825150 Compositions and methods for treating immunological and inflammatory diseases and disorders |
11/02/2010 | US7825149 such as 2-[1-(2-chloro-3-methylphenyl)ethyl]-1H-imidazole, used for the treatment of parasitic infection in plants or animals ; parasiticides |
11/02/2010 | US7825142 imidazole-based compounds such as (1R,2S,3R)-1-(2-(5-methylisoxazol-3-yl)-1H-imidazol-5-yl)butane-1,2,3,4-tetraol, used for the treatment and prevention of inflammatory and autoimmune diseases |
11/02/2010 | CA2389681C Npy y5 antagonist |
11/02/2010 | CA2311456C Imidazonaphthyridines and their use in inducing cytokine biosynthesis |
10/28/2010 | WO2010123150A1 2-aryl imidazoline derivatives |
10/28/2010 | WO2010122995A1 Imidazole compound-containing microcapsulated composition, curable composition using same, and masterbatch type curing agent |
10/28/2010 | WO2010122927A1 Pharmaceutical agent for prevention or treatment of retarded nerve regeneration induced by diabetes |
10/28/2010 | WO2009127338A8 Oxo-heterocyclic substituted carboxylic acid derivates and the use thereof |
10/28/2010 | US20100273849 Metalloproteinase Inhibitors |
10/28/2010 | US20100273848 Iminopyrrolidone thiol amino acid conjugates, pharmaceutical compositions and methods for the treatment of cancer |
10/28/2010 | US20100273833 2-sulfinyl- and 2-sulfonyl-substituted imidazole derivatives and their use as cytokine inhibitors |
10/28/2010 | US20100273801 Betulin derived compounds useful as antibacterial agents |
10/28/2010 | US20100273739 Aminotetraline Derivatives, Pharmaceutical Composition, Containing Them, and Their Use in Therapy |
10/27/2010 | EP2243539A2 Functionalized ionic liquids, and methods of use thereof |
10/27/2010 | EP2242748A1 Therapeutic disulfide compounds for treating pain and diabetes |
10/27/2010 | EP2242746A1 Heterocyclically-substituted imidazolidine-2,4-diones, method for the production thereof, medicaments containing said compounds and use thereof |
10/27/2010 | EP2242745A1 Novel phenyl-substituted imidazolidines, method for the production thereof, medicaments containing said compounds and use thereof |
10/27/2010 | EP2242744A1 Process for working up ionic liquids |
10/27/2010 | EP1279667B1 Process for producing 1,3-dialkyl-2-imidazolidinone compound |
10/27/2010 | CN1819996B Naphthylene derivatives as cytochrome P450 inhibitors |
10/27/2010 | CN101870705A Novel organic compound, light-emitting device, and image display apparatus |
10/27/2010 | CN101870691A 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents |
10/27/2010 | CN101870680A Preparation method and use of tertiary amino functional imidazole ionic liquid |
10/27/2010 | CN101870679A Preparation method of N-(2-aminoethyl)-2-imidazolidone |
10/26/2010 | US7820825 N-substituted-azacyclylamines as histamine-3 antagonists |
10/26/2010 | US7820673 Urea derivative, process for producing the same, and use |
10/26/2010 | CA2293436C Imidazolyl-cyclic acetals as tnf inhibitors |
10/26/2010 | CA2289408C Corrosion inhibitor compositions |
10/21/2010 | WO2010119193A1 Imidazolidine-2,4-dione derivatives, and use thereof as a cancer drug |
10/21/2010 | US20100267962 N-acylic aminoacid derivatives, method for the production thereof, pharmacological composition and the use in the form anti-allergic, anti-inflammatory and hypolipidemic agents |
10/21/2010 | US20100267795 Nitrosubstituted aryloxyalkylimidazolines for use as pesticides |
10/21/2010 | US20100267698 Benzimidazole and Pyridylimidazole Derivatives |
10/21/2010 | CA2758630A1 Imidazolidine-2, 4-dioze derivatives, and use thereof as a cancer drug |
10/21/2010 | CA2758245A1 Gamma-amino-butyric acid derivatives as gabab receptor ligands |
10/20/2010 | EP2241320A1 Aqueous compositions containing metronidazole |
10/20/2010 | EP2240480A2 Derivatives of 2-heteroaroyl-imidazol(1,2-a)pyridine,preparation thereof and therapeutic application thereof |
10/20/2010 | EP2240468A1 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
10/20/2010 | EP2240453A1 Substituted-aryl-2-phenylethyl-1h-imidazole compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors |
10/20/2010 | EP2240019A1 Acid mimic compounds for the inhibition of isoprenyl-s-cysteinyl methyltransferase |
10/20/2010 | EP1780197B1 5-substituted-2-phenylamino benzamides as mek inhibitors |
10/20/2010 | CN101863841A Substituted tetracycline compounds |
10/20/2010 | CN101863837A Water-soluble salt of secnidazole and preparation method thereof |
10/20/2010 | CN101863836A Method for preparing 5,5-diphenyl-2-thiohydantoin |
10/20/2010 | CN101863835A Synthesis method of S-substituted-5,5-diphenyl-2-thiohydantoin derivatives |
10/20/2010 | CN101863834A Preparation method of S-carboxymethyl-5,5-diphenyl-2-thiohydantoin |
10/20/2010 | CN101863833A Preparation method of 3-carboxymethyl-5,5-diphenyl hydantoin |
10/20/2010 | CN101863832A Method for producing miconazole nitrate on industrialized basis |
10/20/2010 | CN101863795A Method for preparing hydrogel material based on 1,4-cyclohexane/phthalic acid |
10/19/2010 | US7816534 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists |
10/19/2010 | US7816522 Triazolone derivatives |
10/19/2010 | US7816389 Organic compounds |
10/19/2010 | US7816387 β secretase inhibitor |
10/19/2010 | US7816375 Ligands for monoamine receptors and transporters, and methods of use thereof |
10/19/2010 | US7816360 MTP inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles |
10/19/2010 | CA2614479C Derivatives of seleno-amino acids |
10/19/2010 | CA2436589C Heterocyclic compounds and cognitive enhancers comprising the same as effective components |
10/19/2010 | CA2436526C Heterocyclic sulfonamide inhibitors of beta amyloid production |
10/19/2010 | CA2214338C Use of .alpha.1l agonists for treating urinary incontinence |
10/14/2010 | WO2010118377A2 Molecular sieves and related methods and structure directing agents |
10/14/2010 | WO2010117108A1 Polyacetylene supramolecular sieve having selectivity for cationic or anionic compounds, and chemical sensor for detecting cationic or anionic compounds using same |
10/14/2010 | WO2010117040A1 Five-membered heterocyclic compound |
10/14/2010 | WO2010116166A2 Process for the preparation of chalcogene compounds |
10/14/2010 | WO2010116165A2 Process for removing metals from hydrocarbons |
10/14/2010 | WO2010115937A1 Process for preparing pyrrolidinium salts |
10/14/2010 | WO2009144395A8 Polysubstituted derivatives of 2-heteroaryl-6-phenyl-imidazo[l,2- α] pyridines, and preparation and therapeutic use thereof |
10/14/2010 | WO2009144394A8 Polysubstituted 2-aryl-6-phenyl-imidazo[1,2-α]pyridine derivatives, and preparation and therapeutic use thereof |
10/14/2010 | US20100261913 Method for producing precursors for l-3,4-dihydroxy-6- [18f] fluorophenyl alaine and 2- [18f] fluoro-l-tyrosine and the alpha-methylated derivatives thereof, precursor, and method for producing l-3, 4dihydroxy-6- [18f] fluorophenylalanine and 2- [18f] fluoro-l-tyrosine and the alpha-methylated derivatives from the precursor |
10/14/2010 | US20100261899 Imidazole compounds |
10/14/2010 | US20100261898 Imidazole compounds |
10/14/2010 | US20100261760 EP2 Receptor Agonists |
10/14/2010 | US20100261758 Heterocyclic amides for use as pharmaceuticals |
10/14/2010 | US20100261631 Biofilm-removing agent |
10/14/2010 | CA2758100A1 Process for preparing pyrrolidinium salts |
10/14/2010 | CA2757854A1 Molecular sieves and related methods and structure directing agents |
10/13/2010 | EP2238980A1 Aqueous compositions containing metronidazole |
10/13/2010 | EP2238116A1 Novel imidazolinylmethyl aryl sulfonamides |
10/13/2010 | EP2238115A1 Novel imidazolinylmethyl aryl sulfonamides |
10/13/2010 | EP2238114A1 Novel imidazolinylmethyl aryl sulfonamides |
10/13/2010 | EP2238113A1 N-[3-bromo-2-chloro-4-(4, 5-dihydro-1h-imidazol-2-ylmethyl)-phenyl] -methanesulfoamide as alpha-1 a adrenergic partial agonist for the treatment of incontinence |
10/13/2010 | EP1370537B1 Metalloproteinase inhibitors |
10/13/2010 | CN1839122B Ioninc liquids based on imidazolium salts incorporating a nitrile functionality |
10/13/2010 | CN101861093A Haloalkylsubstituted aryloxyalkylimidazolines for use as pesticides |
10/13/2010 | CN101468969B Photoresponse ion liquid and preparation thereof |
10/12/2010 | US7812174 Methods of preparing imidazole-based compounds |
10/12/2010 | US7812049 alpha 1-adrenoceptor agonists for treating skin redness; oxymetazoline hydrochloride |
10/12/2010 | US7812048 N-[3-[(2S)-1-methoxypropan-2-yl]oxy-5-(4-methylsulfonylphenoxy)phenyl]-1H-imidazole-5-carboxamide, used as antidiabetic agents, especially for the treatment of non-insulin dependent diabetes |
10/12/2010 | US7812047 4-imidazolines |
10/12/2010 | US7812045 1-(5-(4-trifluoromethyl-benzylamino)-1H-indazol-1-yl)-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ol; 2-(2,4-difluorophenyl)-1-(1H-indazol-1-yl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ol |
10/12/2010 | US7812041 such as 2-Morpholin-4-yl-thiazole-4-carboxylic acid (5,6-dimethyl-1H-benzoimidazol-2-yl)-amide, used for the treatment of dementia, amyotrophic lateral sclerosis, stroke, epilepsy, multiple sclerosis, myasthenia gravis, Huntington's, Alzheimer's, Parkinson's, Meniere's and Creutzfeld-Jacob Disease |